J&J, GSK, and Vir/Alnylam present positive data for hepatitis B treatment candidates, but hopes for a cure remain muted

After a functional cure was found for hepatitis C, pharma companies are now trying to develop antivirals that can eliminate HBV infections. Credit: Shutterstock + Kateryna Kon.



  • hepatitis b